about
Dermatitis artefacta.Psychosocial judgements and perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of adult and peer evaluations.Defining risk factors for red man syndrome in children and adults.A neuropsychiatrist's perspective on selected dermatoses.Psychopharmacological treatment of dermatological patients--when simply talking does not help.Flare-up of pustular psoriasis with fluoxetine: possibility of a serotoninergic influence?Pediatric psychocutaneous disorders: a review of primary psychiatric disorders with dermatologic manifestations.Potential role of neurogenic inflammatory factors in the pathogenesis of vitiligo.The clinical significance of drug interactions between dermatological and psychoactive medications.Inflammatory and Noninflammatory Itch: Implications in Pathophysiology-Directed Treatments.Chronic pruritus: clinics and treatmentIFN-gamma reduction by tricyclic antidepressants.Immunohistochemical study of serotonin in lesions of psoriasis.An Italian study on psoriasis and depression.Effective treatment of uremic pruritus and acquired perforating dermatosis with amitriptyline.Trends, correlates, and disease patterns of antidepressant use among children and adolescents in Taiwan.Development and validation of the psychosomatic scale for atopic dermatitis in adults.Psychological status of patients with chronic urticaria.Itch in familial lichen amyloidosis: effective treatment with amitriptyline in two cases.Pruritus: Progress toward Pathogenesis and Treatment.
P2860
Q34063944-73D8E2DD-73E4-42F8-83F2-8E438C5DCC45Q35208866-25A7BE16-F989-4D27-B54E-B6F57F798C27Q35906008-B1E48558-7B6D-4CD6-A63D-E26460A58FB9Q36363603-BE7F831A-AB29-45F5-AAF6-500EE9C6CAEEQ36945161-0809999A-515B-4F39-9BC1-DE5E639FD94CQ37292486-B5196A1E-1CCA-4C52-8B1D-14A2A1D5FD99Q37872740-0B45EC6C-4B5A-4A6F-8BD3-6AF682A7DF3EQ38025487-6D1F09EA-E90A-4E59-8C9E-8958D6493751Q38185684-0FEA40B3-A5E5-473B-B974-8C22992AE377Q39429573-74ECA062-ED82-4E1B-BE82-FE6C22163EAEQ42089305-6C521186-EADD-4D1C-B1E1-D77BF1BC6E72Q42746526-ECBA466E-98B6-435A-B204-6C1D30F0188BQ44928418-A28D0E29-83FD-46CF-9F5F-21EBF35124A8Q45101688-F96F313E-65D3-47F1-9EDE-BF5C7BB918C1Q45971363-F1C8E9F2-0AD6-43CE-B163-612A5D8F59D4Q48638481-4498FC49-1A9B-4877-ADBF-C3DFF9AD51B1Q51795244-91260C27-6487-4C5B-883D-5D30F960098EQ51910768-54EEF6B5-7BAB-4136-A737-D7DCEA580F8EQ54312728-65F42095-752F-419B-AA05-A8659804F18CQ55076872-5DC6475D-ED05-4309-BBC0-6C2DD2047F8B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
The use of antidepressant drugs in dermatology.
@ast
The use of antidepressant drugs in dermatology.
@en
The use of antidepressant drugs in dermatology.
@nl
type
label
The use of antidepressant drugs in dermatology.
@ast
The use of antidepressant drugs in dermatology.
@en
The use of antidepressant drugs in dermatology.
@nl
prefLabel
The use of antidepressant drugs in dermatology.
@ast
The use of antidepressant drugs in dermatology.
@en
The use of antidepressant drugs in dermatology.
@nl
P2860
P1476
The use of antidepressant drugs in dermatology.
@en
P2093
P2860
P304
P356
10.1046/J.1468-3083.2001.00278.X
P577
2001-11-01T00:00:00Z